Clinical Trials
2
Active:0
Completed:1
Trial Phases
1 Phases
Phase 3:2
Drug Approvals
31
FDA:29
SFDA:2
Drug Approvals
- Prev
- 1
- 2
- 3
- Next
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
Phase 3
2 (100.0%)Efficacy and Safety of Tranexamic Acid in Spinal Fusion Surgery
Phase 3
Terminated
- Conditions
- Spinal Fusion
- Interventions
- Drug: Sodium Chloride 0.9% Inj
- First Posted Date
- 2018-02-08
- Last Posted Date
- 2021-06-21
- Lead Sponsor
- Exela Pharma Sciences, LLC.
- Target Recruit Count
- 5
- Registration Number
- NCT03425799
- Locations
- 🇺🇸
Memorial Orthopaedic Surgery Group, Long Beach, California, United States
🇺🇸Cedars-Sinai Medical Center, Los Angeles, California, United States
🇺🇸Rush University Medical Center - Division of Spine Surgery, Chicago, Illinois, United States
Comparative Efficacy and Safety of Ciprofloxacin 0.3% and Dexamethasone 0.1% in Acute Otitis Externa
Phase 3
Completed
- Conditions
- Acute Otitis Externa
- Interventions
- First Posted Date
- 2014-08-13
- Last Posted Date
- 2021-05-28
- Lead Sponsor
- Exela Pharma Sciences, LLC.
- Target Recruit Count
- 499
- Registration Number
- NCT02216071
- Locations
- 🇺🇸
Birmingham Pediatric Associates, Birmingham, Alabama, United States
🇺🇸Desert Clinical Research/Clinical Research Advantage, Inc., Mesa, Arizona, United States
🇺🇸Children's Clinic of Jonesboro, PA, Jonesboro, Arkansas, United States
News
No news found